Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases
Atrial Flutter Clinical Trials
A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
Clarification of Optimal Anticoagulation Through Genetics
Birmingham : University of Alabama at Birmingham
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
California
Fullerton : St. Jude Medical Center
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
San Francisco : University of California San Francisco
Clarification of Optimal Anticoagulation Through Genetics
Colorado
Colorado Springs : Colorado Springs Cardiologist, P.C.
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Connecticut
Danbury : Danbury Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
District of Columbia
Washington : Washington Hospital Center
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Florida
Gainesville : University of Florida
Clarification of Optimal Anticoagulation Through Genetics
Hudson : West Coast Arrhythmia Center
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Georgia
Atlanta : Emory University Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Augusta : Georgia Health Sciences University
Clarification of Optimal Anticoagulation Through Genetics
Kentucky
Lexington : Central Baptist Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Louisiana
New Orleans : Tulane University Health Science Center
Clarification of Optimal Anticoagulation Through Genetics
Maryland
Baltimore : University of Maryland School of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Massachusetts
Boston : Caritas St. Elizabeth's Medical Center
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Boston : Brigham and Women's Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Michigan
Detroit : Henry Ford Hospital
Clarification of Optimal Anticoagulation Through Genetics
Minnesota
Rochester : Mayo Clinic College of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Missouri
St. Louis : Washington University School of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Nebraska
Lincoln : Nebraska Heart Institute
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
New York
Bronx : Montefiore Medical Center
Clarification of Optimal Anticoagulation Through Genetics
New York : Mount Sinai School of Medicine
Clarification of Optimal Anticoagulation Through Genetics
Rochester : Strong Memorial Hospital of the University of Rochester
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
North Carolina
Durham : Duke University
Clarification of Optimal Anticoagulation Through Genetics
Greensboro : Moses H. Cone Memorial Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Ohio
Cleveland : Cleveland Clinic Foundation
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Columbus : Ohio State University Medical Center
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Toledo : ProMedica Toledo Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Pennsylvania
Philadelphia : Hospital of the University of Pennsylvania
Clarification of Optimal Anticoagulation Through Genetics
South Carolina
Charleston : Medical University of South Carolina
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Tennessee
Nashville : Vanderbilt University
Clarification of Optimal Anticoagulation Through Genetics
Texas
Austin : Texas Cardiac Arrhythmia Research
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Galveston : University of Texas Medical Branch
Clarification of Optimal Anticoagulation Through Genetics
Houston : Hall Garcia Cardiology
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Utah
Murray : Intermountain Medical Center
Clarification of Optimal Anticoagulation Through Genetics
Salt Lake City : University of Utah Health Care
Clarification of Optimal Anticoagulation Through Genetics
Virginia
Norfolk : Sentara Norfolk General Hospital
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Washington
Seattle : Swedish Medical Center
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
Wisconsin
Marshfield : Marshfield Clinical Research Foundation
Clarification of Optimal Anticoagulation Through Genetics
Canada
London : London Health Sciences Center
Tricuspid Isthmus Imaged by CARTOsound, Patients With Typical Atrial Flutter
France
Grenoble : CHU Grenoble
Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation
Rennes : CHU de Rennes
Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation
Rouen : University Hospital of Rouen
Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation
Saint-etienne : CHU de Saint-Etienne
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Toulouse : Clinique Pasteur
Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation
Israel
Ashkelon :
Safety and Efficacy of Single Oral Doses of Vanoxerine for Conversion of Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm
Nazareth :
Safety and Efficacy of Single Oral Doses of Vanoxerine for Conversion of Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm
Safed :
Safety and Efficacy of Single Oral Doses of Vanoxerine for Conversion of Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm
Russian Federation
Moscow :
Safety and Efficacy of Single Oral Doses of Vanoxerine for Conversion of Atrial Fibrillation or Flutter of Recent Onset to Normal Sinus Rhythm
